Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Windecker

Showing results (951-960 of 1,158) with videos related to

Pageof 116
Sort By:
JACC. Cardiovascular Interventions|April 23, 2011
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers TrialScot Garg, Patrick W Serruys, Sigmund Silber, et al.
Journal of the American College of Cardiology|May 28, 2011
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention)Giulio G Stefanini, Patrick W Serruys, Sigmund Silber, et al.
Journal of the American Heart Association|March 17, 2023
Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid RegurgitationVera Fortmeier, Mark Lachmann, Matthias Unterhuber, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2025
Long-term structural valve deterioration after TAVI: insights from the EORP ESC Valve Durability TAVI RegistryCristina Giannini, Davide Capodanno, Gabor G Toth, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 10, 2019
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trialKuniaki Takahashi, Ply Chichareon, Rodrigo Modolo, et al.
Journal of the American College of Cardiology|July 9, 2011
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mmRoberto Diletti, Yoshinobu Onuma, Vasim Farooq, et al.
Circulation. Cardiovascular Imaging|November 19, 2024
Association of Lipoprotein(a) With Changes in Coronary Atherosclerosis in Patients Treated With AlirocumabKonstantinos C Koskinas, Jonas Häner, Yasushi Ueki, et al.
JACC. Cardiovascular Interventions|April 12, 2023
Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT TrialAntonio Landi, Dik Heg, Enrico Frigoli, et al.
The Canadian Journal of Cardiology|March 7, 2020
Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERSAna Paula de Faria, Rodrigo Modolo, Ply Chichareon, et al.
Lancet (London, England)|September 1, 2018
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trialPascal Vranckx, Marco Valgimigli, Peter Jüni, et al.
Pageof 116

Showing results (951-960 of 1,158) with videos related to

Sort By:
Pageof 116
JACC. Cardiovascular Interventions|April 23, 2011
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers TrialScot Garg, Patrick W Serruys, Sigmund Silber, et al.
Journal of the American College of Cardiology|May 28, 2011
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention)Giulio G Stefanini, Patrick W Serruys, Sigmund Silber, et al.
Journal of the American Heart Association|March 17, 2023
Epiphenomenon or Prognostically Relevant Interventional Target? A Novel Proportionality Framework for Severe Tricuspid RegurgitationVera Fortmeier, Mark Lachmann, Matthias Unterhuber, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2025
Long-term structural valve deterioration after TAVI: insights from the EORP ESC Valve Durability TAVI RegistryCristina Giannini, Davide Capodanno, Gabor G Toth, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 10, 2019
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trialKuniaki Takahashi, Ply Chichareon, Rodrigo Modolo, et al.
Journal of the American College of Cardiology|July 9, 2011
6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5 mmRoberto Diletti, Yoshinobu Onuma, Vasim Farooq, et al.
Circulation. Cardiovascular Imaging|November 19, 2024
Association of Lipoprotein(a) With Changes in Coronary Atherosclerosis in Patients Treated With AlirocumabKonstantinos C Koskinas, Jonas Häner, Yasushi Ueki, et al.
JACC. Cardiovascular Interventions|April 12, 2023
Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT TrialAntonio Landi, Dik Heg, Enrico Frigoli, et al.
The Canadian Journal of Cardiology|March 7, 2020
Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERSAna Paula de Faria, Rodrigo Modolo, Ply Chichareon, et al.
Lancet (London, England)|September 1, 2018
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trialPascal Vranckx, Marco Valgimigli, Peter Jüni, et al.
Pageof 116